Journal News

Are microbes the key to preventing postsurgical gallstones?

Brianna Alexander
By Brianna Alexander
April 6, 2023

A nearly 70-year-old procedure, bariatric surgery, or BS, continues to gain momentum as a popular approach to combat morbid obesity. The procedure results in dramatic weight loss over a short period of time. However, studies have reported that about 40% of BS patients develop gallstones after surgery, and these rocklike deposits of bile fluid can cause severe pain when they block a bile duct.

So why do some patients develop gallstones, while others do not?

Researchers found that Enterobacteriaceae, such as the one shown here, and Lactobacillaceae, were abundant in bariatric surgery patients who did not develop gallstones.
Jennifer Oosthuizen/Centers for Disease Control and Prevention
Researchers found that Enterobacteriaceae, such as the one shown here, and Lactobacillaceae, were abundant in bariatric surgery patients who did not develop gallstones.

Maimoena S.S. Guman, a researcher at Amsterdam University Medical Centers who already had found that gallstones form differently in BS patients than in the general population, reported recently in the Journal of Lipid Research on efforts to answer this question.

“The unique part of this research is that this is the first attempt to investigate protective mechanisms instead of causality for gallstone development,” Guman stated in an email.

To identify baseline differences between BS patients who did and did not develop gallstones, Guman’s team studied 88 patients, analyzing three metrics prior to surgery: the fasting metabolome, the liver and adipose transcriptome, and the gut microbiome. They monitored gallstone development after surgery and analyzed differences in each population for possible protecting factors. In line with previous reports, they found that 32 of the 88 patients, or 36.4%, developed gallstones or sludge (which precedes gallstones) or reported gallstone symptoms within two years of the procedure.

The metabolic analysis showed higher concentrations of plasma metabolites, including a number of conjugated bile acids, in the patients with gallstones. In the same patient group, transcriptomic analysis showed the upregulated expression of 15 genes related to processes including cell division, cholesterol/fatty acid metabolism and tissue inflammation.

In analyzing the gut microbiome, Guman’s team found differentially expressed strains between the patient groups. Four of these strains were enriched in patients with gallstones, includingRuminococcus gnavus, a biomarker for gallstones. Patients who did not develop gallstones, however, had an enrichment in 37 different strains of bacteria, 7 belonging to the Enterobacteriaceae family and 12 to the Lactobacillae family, including a strain used in the making of yogurt: Lactobacillus casei.

When asked if a simple probiotic source, like yogurt, could help protect against gallstone development, Guman wrote, “Based on our results it would be too early to conclude that a simple intervention as having yoghurt enriched with Lactobacillaceae would help, although this finding has been described previously. An intervention study with one group having Lactobacillaceae, either in yoghurt or maybe as supplement pills, would be needed to prove this relationship.”

This study was driven by the desire to gain knowledge that could help protect BS patients from gallstone development. Guman’s team has identified factors that may lead to that goal while opening doors for new avenues of research.

“Prevention is better than cure,” Guman wrote, “but first, we need more research, and I hope this work has inspired others to keep digging further.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Brianna Alexander
Brianna Alexander

Brianna Alexander recently obtained her PhD in biomedical sciences from Rutgers University and is now a medical writer.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Transforming learning through innovation and collaboration
Award

Transforming learning through innovation and collaboration

Nov. 22, 2024

Neena Grover will receive the William C. Rose Award for Exemplary Contributions to Education at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Guiding grocery carts to shape healthy habits
Award

Guiding grocery carts to shape healthy habits

Nov. 21, 2024

Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.

Quantifying how proteins in microbe and host interact
Journal News

Quantifying how proteins in microbe and host interact

Nov. 20, 2024

“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.

Leading the charge for gender equity
Award

Leading the charge for gender equity

Nov. 19, 2024

Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.

CRISPR gene editing: Moving closer to home
News

CRISPR gene editing: Moving closer to home

Nov. 17, 2024

With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.

Finding a missing piece for neurodegenerative disease research
News

Finding a missing piece for neurodegenerative disease research

Nov. 16, 2024

Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.